News

Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland

Merck, invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development See full press release here.

Merck, invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development

Interested in Life Science Training?
Discover more
Ribbon Left - ATSTN
Ribbon Right - ATSTN

Book a 30-minute demo to see how the Life Sciences Learner Hub supports your learning.